Prosomnus Inc Quick Ratio (OSA) starting from the second quarter 2024 to second quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Prosomnus Inc   (NASDAQ: OSA)

Prosomnus Inc 's Quick Ratio

OSA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Prosomnus Inc 's Cash & cash equivalent grew by 27.01 % in the Q2 2024 sequentially, while Current Liabilities decreased, this led to improvement in Prosomnus Inc 's Quick Ratio to 0.26, Quick Ratio remained below Prosomnus Inc average.

Within Medical Equipment & Supplies industry 161 other companies have achieved higher Quick Ratio than Prosomnus Inc in second quarter 2024. While Quick Ratio total ranking in the second quarter 2024 has deteriorated compared to the prior quarter from 2399 to 2773.

Explain Quick Ratio?
How much Cash & cash equivalents OSA´s has?
What are OSA´s Current Liabilities?




OSA Quick Ratio (Jun 30 2024)
Q2
(Mar 31 2024)
Q1
(Dec 31 2023)
Q4
(Sep 30 2023)
Q3
(Jun 30 2023)
Q2
Y / Y Current Liabilities Change 111.7 % 419.29 % 102.26 % 150.49 % -
Y / Y Cash & cash equivalent Change -14.1 % -63.87 % -55.62 % 701.14 % -
Quick Ratio MRQ 0.26 0.11 0.49 1.04 0.65
OSA's Total Ranking # 2773 # 2399 # 2224 # 982 # 1322
Seq. Current Liabilities Change -48.61 % 171.65 % 23.87 % 22.43 % 26.05 %
Seq. Cash & cash equivalent Change 27.01 % -40.86 % -41.25 % 94.67 % -46.58 %



Quick Ratio second quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 162
Healthcare Sector # 810
Overall Market # 2773


Quick Ratio Statistics
High Average Low
2.24 0.91 0.11
(Dec 31 2022)   (Mar 31 2024)




Financial Statements
Prosomnus Inc 's Current Liabilities $ 20 Millions Visit OSA's Balance sheet
Prosomnus Inc 's Cash & cash equivalent $ 5 Millions Visit OSA's Balance sheet
Source of OSA's Sales Visit OSA's Sales by Geography


Cumulative Prosomnus Inc 's Quick Ratio

OSA's Quick Ratio for the trailling 12 Months

OSA Quick Ratio

(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
(Sep 30 2023)
12 Months
(Jun 30 2023)
12 Months
Y / Y Current Liabilities TTM Growth 196.1 % 286.86 % 266.08 % 670.79 % -
Y / Y Cash & cash equivalent TTM Growth -18.73 % 1.59 % 111.41 % 2943.72 % -
Quick Ratio TTM 0.34 0.4 0.86 1.28 1.23
Total Ranking TTM # 3641 # 2623 # 1452 # 3733 # 1781
Seq. Current Liabilities TTM Growth 14.21 % 73.36 % 20.35 % 24.26 % 49.21 %
Seq. Cash & cash equivalent TTM Growth -2.96 % -20.05 % -19.38 % 29.93 % 21.31 %


On the trailing twelve months basis Due to drop in Current Liabilities in the Q2 2024 to $20.02 millions, cumulative Quick Ratio decreased to 0.34 below the Prosomnus Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 220 other companies have achieved higher Quick Ratio than Prosomnus Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2024 from 2623 to 3641.

Explain Quick Ratio?
How much Cash & cash equivalents OSA´s has?
What are OSA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 221
Healthcare Sector # 971
Within the Market # 3641


trailing twelve months Quick Ratio Statistics
High Average Low
1.28 0.79 0.34
(Sep 30 2023)   (Jun 30 2024)




Companies with similar Quick Ratio in the quarter ending Jun 30 2024, within Medical Equipment & Supplies Industry Quick RatioJun 30 2024 MRQ Cash & cash equivalentJun 30 2024 MRQ Current Liabilities
Streamex Corp   0.71 $ 2.104  Millions$ 2.976  Millions
West Pharmaceutical Services Inc   0.70 $ 446.200  Millions$ 633.700  Millions
Pro dex Inc   0.70 $ 6.848  Millions$ 9.810  Millions
Sonoma Pharmaceuticals Inc   0.69 $ 2.589  Millions$ 3.751  Millions
Nuo Therapeutics Inc   0.69 $ 0.473  Millions$ 0.690  Millions
Icu Medical Inc  0.59 $ 302.648  Millions$ 511.907  Millions
Sharps Technology Inc   0.58 $ 1.483  Millions$ 2.553  Millions
Tenon Medical Inc   0.58 $ 1.968  Millions$ 3.403  Millions
Dexcom Inc   0.56 $ 939.200  Millions$ 1,685.900  Millions
Zimvie Inc   0.56 $ 78.601  Millions$ 141.124  Millions
Sanara Medtech Inc   0.53 $ 6.150  Millions$ 11.566  Millions
Boston Scientific Corporation  0.52 $ 2,913.000  Millions$ 5,576.000  Millions
Align Technology inc   0.52 $ 782.111  Millions$ 1,511.521  Millions
Pavmed Inc   0.49 $ 25.499  Millions$ 52.021  Millions
Star Equity Holdings Inc   0.49 $ 6.290  Millions$ 12.951  Millions
Strata Skin Sciences Inc  0.49 $ 5.483  Millions$ 11.301  Millions
Avanos Medical Inc   0.48 $ 92.200  Millions$ 193.800  Millions
Plus Therapeutics Inc   0.45 $ 8.435  Millions$ 18.787  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.43 $ 4.581  Millions$ 10.558  Millions
Stryker Corp  0.43 $ 1,998.000  Millions$ 4,620.000  Millions
Docgo Inc   0.43 $ 66.060  Millions$ 154.117  Millions
Teleflex Incorporated  0.43 $ 238.567  Millions$ 556.751  Millions
Smith and Nephew Plc  0.43 $ 653.000  Millions$ 1,531.000  Millions
Rosecliff Acquisition Corp I  0.43 $ 6.877  Millions$ 16.126  Millions
Adm Tronics Unlimited Inc   0.42 $ 0.469  Millions$ 1.108  Millions
Msa Safety Inc  0.42 $ 146.830  Millions$ 351.751  Millions
Nexgel Inc   0.41 $ 1.069  Millions$ 2.633  Millions
Lifestance Health Group Inc   0.38 $ 86.969  Millions$ 227.659  Millions
Atrion Corporation  0.35 $ 6.124  Millions$ 17.537  Millions
Ufp Technologies Inc   0.32 $ 16.728  Millions$ 51.787  Millions

Date modified: 2026-09-08T15:11:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.